IRIS Accounts Production v24.1.0.578 07441542 Board of Directors 1.12.22 30.11.23 30.11.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074415422022-11-30074415422023-11-30074415422022-12-012023-11-30074415422021-11-30074415422021-12-012022-11-30074415422022-11-3007441542ns15:EnglandWales2022-12-012023-11-3007441542ns14:PoundSterling2022-12-012023-11-3007441542ns10:Director12022-12-012023-11-3007441542ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3007441542ns10:SmallEntities2022-12-012023-11-3007441542ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3007441542ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3007441542ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3007441542ns10:AbridgedAccounts2022-12-012023-11-3007441542ns10:OrdinaryShareClass12022-12-012023-11-3007441542ns10:Director22022-12-012023-11-3007441542ns10:RegisteredOffice2022-12-012023-11-3007441542ns5:CurrentFinancialInstruments2023-11-3007441542ns5:CurrentFinancialInstruments2022-11-3007441542ns5:ShareCapital2023-11-3007441542ns5:ShareCapital2022-11-3007441542ns5:RetainedEarningsAccumulatedLosses2023-11-3007441542ns5:RetainedEarningsAccumulatedLosses2022-11-3007441542ns5:FurnitureFittings2022-12-012023-11-3007441542ns5:ComputerEquipment2022-12-012023-11-3007441542ns10:OrdinaryShareClass12023-11-30
REGISTERED NUMBER: 07441542 (England and Wales)












Financial Statements

for the Year Ended 30 November 2023

for

Haematology Medical Services Limited

Haematology Medical Services Limited (Registered number: 07441542)






Contents of the Financial Statements
for the Year Ended 30 November 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


Haematology Medical Services Limited

Company Information
for the Year Ended 30 November 2023







DIRECTORS: Dr H N Ahmad
Mrs S O Ahmad





REGISTERED OFFICE: 47a Queen Street
Derby
DE1 3DE





REGISTERED NUMBER: 07441542 (England and Wales)





ACCOUNTANTS: Bourne & Co.
Chartered Accountants
47a Queen Street
Derby
Derbyshire
DE1 3DE

Haematology Medical Services Limited (Registered number: 07441542)

Abridged Balance Sheet
30 November 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,489 2,101

CURRENT ASSETS
Debtors 14 156
Cash at bank 128,195 105,458
128,209 105,614
CREDITORS
Amounts falling due within one year 7,747 8,566
NET CURRENT ASSETS 120,462 97,048
TOTAL ASSETS LESS CURRENT
LIABILITIES

121,951

99,149

PROVISIONS FOR LIABILITIES 283 399
NET ASSETS 121,668 98,750

CAPITAL AND RESERVES
Called up share capital 5 100 100
Retained earnings 121,568 98,650
SHAREHOLDERS' FUNDS 121,668 98,750

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 30 November 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 June 2024 and were signed on its behalf by:





Dr H N Ahmad - Director


Haematology Medical Services Limited (Registered number: 07441542)

Notes to the Financial Statements
for the Year Ended 30 November 2023

1. STATUTORY INFORMATION

Haematology Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is represented by the sale of services provided excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Computer equipment - 33% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial assets and liabilities
Short term debtors are measured at transaction price, less any impairment.

Short term creditors are measured at transaction price, less any impairment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 3 ) .

Haematology Medical Services Limited (Registered number: 07441542)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 December 2022 3,568
Additions 495
Disposals (142 )
At 30 November 2023 3,921
DEPRECIATION
At 1 December 2022 1,467
Charge for year 1,107
Eliminated on disposal (142 )
At 30 November 2023 2,432
NET BOOK VALUE
At 30 November 2023 1,489
At 30 November 2022 2,101

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100